KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Gains from Investment Securities (2016 - 2025)

Repligen (RGEN) has disclosed Gains from Investment Securities for 16 consecutive years, with $20.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 2705.23% to $20.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.9 million, a 884.5% increase, with the full-year FY2025 number at $8.8 million, up 1381.53% from a year prior.
  • Gains from Investment Securities was $20.9 million for Q4 2025 at Repligen, up from -$8.7 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $34.6 million in Q4 2022 to a low of -$32.0 million in Q3 2023.
  • A 5-year average of $955718.3 and a median of $598534.0 in 2025 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: crashed 83233.33% in 2021, then soared 2705.23% in 2025.
  • Repligen's Gains from Investment Securities stood at -$2.1 million in 2021, then surged by 1733.98% to $34.6 million in 2022, then plummeted by 97.98% to $697000.0 in 2023, then plummeted by 215.21% to -$803000.0 in 2024, then skyrocketed by 2705.23% to $20.9 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Gains from Investment Securities are $20.9 million (Q4 2025), -$8.7 million (Q3 2025), and $598534.0 (Q1 2025).